202 related articles for article (PubMed ID: 35945009)
1. A Novel Development of Sarcoidosis Following COVID-19 Vaccination and a Literature Review.
Numakura T; Murakami K; Tamada T; Yamaguchi C; Inoue C; Ohkouchi S; Tode N; Sano H; Aizawa H; Sato K; Mitsune A; Kurosawa H; Nakazawa T; Sugiura H
Intern Med; 2022 Oct; 61(20):3101-3106. PubMed ID: 35945009
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 mRNA Vaccine-Associated Uveitis Leading to Diagnosis of Sarcoidosis: Case Report and Review of Literature.
Matsuo T; Honda H; Tanaka T; Uraguchi K; Kawahara M; Hagiya H
J Investig Med High Impact Case Rep; 2022; 10():23247096221086450. PubMed ID: 35313760
[TBL] [Abstract][Full Text] [Related]
3. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.
Yamada M; Sada RM; Kashihara E; Okubo G; Matsushita S; Manabe A; Tagawa S; Akebo H; Miyake H; Hatta K
J Infect Chemother; 2022 Jul; 28(7):1008-1011. PubMed ID: 35428576
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y; Hasegawa E; Keino H; Usui Y; Maruyama K; Yamamoto Y; Kaburaki T; Iwata D; Takeuchi M; Kusuhara S; Takase H; Nagata K; Yanai R; Kaneko Y; Iwahashi C; Fukushima A; Ohguro N; Sonoda KH;
Jpn J Ophthalmol; 2023 Jan; 67(1):14-21. PubMed ID: 36417027
[TBL] [Abstract][Full Text] [Related]
5. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
[TBL] [Abstract][Full Text] [Related]
6. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
7. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization.
Khehra N; Padda I; Jaferi U; Atwal H; Narain S; Parmar MS
AAPS PharmSciTech; 2021 Jun; 22(5):172. PubMed ID: 34100150
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
9. Multiple Evanescent White Dot Syndrome following COVID-19 mRNA Vaccination in Two Patients.
Smith E; Tran T; Gillies A; Yeung S; Ma PE
Ocul Immunol Inflamm; 2022 Jul; 30(5):1240-1243. PubMed ID: 35201960
[TBL] [Abstract][Full Text] [Related]
10. BNT162b2 mRNA COVID-19 Vaccine: First Approval.
Lamb YN
Drugs; 2021 Mar; 81(4):495-501. PubMed ID: 33683637
[TBL] [Abstract][Full Text] [Related]
11. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
Kim JE; Park J; Min YG; Hong YH; Song TJ
J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
[TBL] [Abstract][Full Text] [Related]
12. [COVID-19 vaccination for allogeneic hematopoietic stem cell recipients].
Nagafuji K
Rinsho Ketsueki; 2022; 63(9):1067-1077. PubMed ID: 36198531
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects.
Pham MN; Murugesan K; Banaei N; Pinsky BA; Tang M; Hoyte E; Lewis DB; Gernez Y
J Allergy Clin Immunol; 2022 Mar; 149(3):907-911.e3. PubMed ID: 34952033
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.
Kim Y; Kang J; Lee SG; Kim GT
Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834
[TBL] [Abstract][Full Text] [Related]
15. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
17. Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study.
Ripabelli G; Tamburro M; Buccieri N; Adesso C; Caggiano V; Cannizzaro F; Di Palma MA; Mantuano G; Montemitro VG; Natale A; Rodio L; Sammarco ML
J Community Health; 2022 Apr; 47(2):211-225. PubMed ID: 34628568
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination.
Aydoğan Bİ; Ünlütürk U; Cesur M
Endocrine; 2022 Oct; 78(1):42-46. PubMed ID: 35809159
[TBL] [Abstract][Full Text] [Related]
19. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases.
Çınar OE; Erdoğdu B; Karadeniz M; Ünal S; Malkan ÜY; Göker H; Haznedaroğlu İC
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36363532
[TBL] [Abstract][Full Text] [Related]
20. Comment on "Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines".
Al-Ahmad A
J Immunol; 2024 Mar; 212(5):753. PubMed ID: 38377475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
